An increasing number of studies indicate that RTP4 can serve as one of the important markers of diagnosis or prognosis of various diseases, such as cutaneous melanoma, breast cancer, type 2 diabetes and viral infection [18,32,33,34]. Here, RTP4 is linked to cutaneous melanoma.